Technical and implementation issues in using next-generation sequencing of cancers in clinical practice

Area of Science:

• Genomic Medicine
• Oncology
• Bioinformatics

Background:

• Next-generation sequencing (NGS) is transforming cancer research and clinical practice.
• NGS enables the identification of somatic mutations for targeted drug development, outcome prediction, and tumor classification.
• The decreasing cost and increasing speed of NGS technologies facilitate broader application in oncology.

Purpose of the Study:

• To review the revolutionary potential of next-generation sequencing (NGS) in oncology.
• To identify the technical challenges and clinical decision-making hurdles associated with NGS data.
• To emphasize the need for standardized data collection and reliable biomarker identification for personalized medicine.

Main Methods:

• Review of current literature on next-generation sequencing in cancer genomics.
• Analysis of technical challenges in sequencing low-quality samples, structural variations, and intratumor heterogeneity.
• Discussion of the clinical utility and potential pitfalls of using NGS data for patient management.

Main Results:

• NGS provides unprecedented capability for identifying clinically significant somatic mutations.
• Technical challenges remain in sample quality, variation identification, and heterogeneity assessment.
• Clinical application of NGS data is complex, risking premature use without robust evidence.

Conclusions:

• NGS holds immense promise for revolutionizing cancer care through personalized medicine.
• Addressing technical and data interpretation challenges is crucial for clinical implementation.
• Standardized, international data collection and reliable biomarker discovery are essential next steps for optimizing patient care.